Our reviews
| Status | Stage |
|---|---|
- Acamprosate for alcohol dependence
- Alcoholics Anonymous and other 12-step programmes for alcohol dependence
- Alcoholics Anonymous and other 12-step programs for alcohol use disorder
- Alpha-adrenergic agonists for the management of opioid withdrawal
- Anticonvulsants for alcohol dependence
- Anticonvulsants for alcohol withdrawal
- Anticonvulsants for cocaine dependence
- Antidepressants for cocaine dependence and problematic cocaine use
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence
- Antipsychotic medications for cocaine dependence
- Auricular acupuncture for cocaine dependence
- Baclofen for alcohol use disorder
- Baclofen for alcohol withdrawal
- Benzodiazepines for alcohol withdrawal
- Brief alcohol questionnaires for identifying hazardous, harmful and dependent alcohol use in primary care
- Brief interventions for heavy alcohol users admitted to general hospital wards
- Brief school-based interventions and behavioural outcomes for substance-using adolescents
- Buprenorphine for managing opioid withdrawal
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
- Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders
- Detoxification treatments for opiate dependent adolescents
- Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders
- Disulfiram for the treatment of cocaine dependence
- Dopamine agonists for the treatment of cocaine dependence
- Effectiveness of brief alcohol interventions in primary care populations
- Effectiveness of psychosocial interventions for reducing parental substance misuse
- Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome
- Family-based prevention programmes for alcohol use in young people
- Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Heroin maintenance for chronic heroin-dependent individuals
- Individual-, family-, and school-level interventions for preventing multiple risk behaviours relating to alcohol, tobacco and drug use in individuals aged 8 to 25 years
- Inpatient versus other settings for detoxification for opioid dependence
- Interventions for drug-using offenders with co-occurring mental health problems
- Interventions for female drug-using offenders
- Interventions for prevention of drug use by young people delivered in non-school settings
- Interventions to build resilience in children of problem drinkers
- LAAM maintenance vs methadone maintenance for heroin dependence
- Magnesium for alcohol withdrawal
- Maintenance agonist treatments for opiate-dependent pregnant women
- Maintenance treatments for opiate -dependent adolescents
- Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse
- Media campaigns for the prevention of illicit drug use in young people
- Mentoring adolescents to prevent drug and alcohol use
- Methadone at tapered doses for the management of opioid withdrawal
- Methadone maintenance at different dosages for opioid dependence
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
- Mindfulness-based interventions for substance use disorders
- Motivational interviewing for substance use reduction
- Motivational interviewing for the prevention of alcohol misuse in young adults
- Music therapy for people with substance use disorders
- Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
- Opioid agonist treatment for people who are dependent on pharmaceutical opioids
- Opioid antagonists for alcohol dependence
- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
- Opioid antagonists with minimal sedation for opioid withdrawal
- Oral naltrexone maintenance treatment for opioid dependence
- Oral substitution treatment of injecting opioid users for prevention of HIV infection
- Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
- Pharmacological interventions for drug-using offenders
- Pharmacological therapies for maintenance treatments of opium dependence
- Pharmacological therapies for management of opium withdrawal
- Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
- Pharmacotherapies for cannabis dependence
- Primary care versus specialty care management of opioid use disorder
- Psychological interventions for co-occurring depression and substance use disorders
- Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy
- Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries
- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
- Psychosocial interventions for benzodiazepine harmful use, abuse or dependence
- Psychosocial interventions for cannabis abuse and/or dependence among persons with co-occurring cannabis use and psychotic disorders
- Psychosocial interventions for cannabis use disorder
- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions
- Psychosocial interventions for stimulant use disorder
- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy.
- Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
- Psychostimulant drugs for cocaine dependence
- Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
- QTc interval screening for cardiac risk in methadone treatment of opioid dependence
- Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents
- Social norms information for alcohol misuse in university and college students
- Supervised dosing with a long-acting opioid medication in the management of opioid dependence
- Sustained-Release Naltrexone For Opioid Dependence
- Therapeutic communities for substance related disorder
- Treatment for amphetamine psychosis
- Treatment for amphetamine withdrawal
- Treatment for inhalant dependence and abuse
- Treatment for Methaqualone dependence in adults
- Universal family-based prevention programs for alcohol misuse in young people
- Universal multi-component prevention programs for alcohol misuse in young people
- Universal school-based prevention for illicit drug use
- Universal school-based prevention programs for alcohol misuse in young people
- Cannabis and cannabinoids for people with multiple sclerosis
- Impact of exposure to alcohol marketing and subsequent drinking patterns among youth and young adults
- What are the effects of combined psychosocial interventions and medications for helping people who consume an excessive amount of alcohol?New
- Opioids abuse and dependence (29)
- Preventive interventions (1)
- Pharmacological detoxification interventions (8)
- Buprenorphine for managing opioid withdrawal
- Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders
- Alpha-adrenergic agonists for the management of opioid withdrawal
- Detoxification treatments for opiate dependent adolescents
- Pharmacological therapies for management of opium withdrawal
- Methadone at tapered doses for the management of opioid withdrawal
- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
- Opioid antagonists with minimal sedation for opioid withdrawal
- Pharmacological maintenance interventions (15)
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
- Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders
- LAAM maintenance vs methadone maintenance for heroin dependence
- Maintenance treatments for opiate -dependent adolescents
- Maintenance agonist treatments for opiate-dependent pregnant women
- Methadone maintenance at different dosages for opioid dependence
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
- Opioid agonist treatment for people who are dependent on pharmaceutical opioids
- Oral naltrexone maintenance treatment for opioid dependence
- Oral substitution treatment of injecting opioid users for prevention of HIV infection
- Sustained-Release Naltrexone For Opioid Dependence
- Heroin maintenance for chronic heroin-dependent individuals
- Pharmacological therapies for maintenance treatments of opium dependence
- Primary care versus specialty care management of opioid use disorder
- Supervised dosing with a long-acting opioid medication in the management of opioid dependence
- Psychosocial interventions (2)
- Opioid acute intoxication interventions (0)
- Other (3)
- Alcohol abuse and dependence (36)
- Preventive interventions (6)
- Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents
- Universal family-based prevention programs for alcohol misuse in young people
- Family-based prevention programmes for alcohol use in young people
- Universal school-based prevention programs for alcohol misuse in young people
- Social norms information for alcohol misuse in university and college students
- Universal multi-component prevention programs for alcohol misuse in young people
- Pharmacological interventions (16)
- Acamprosate for alcohol dependence
- Anticonvulsants for alcohol dependence
- Anticonvulsants for alcohol withdrawal
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence
- Baclofen for alcohol use disorder
- Baclofen for alcohol withdrawal
- Benzodiazepines for alcohol withdrawal
- Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries
- Magnesium for alcohol withdrawal
- Opioid antagonists for alcohol dependence
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
- Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome
- Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy
- What are the effects of combined psychosocial interventions and medications for helping people who consume an excessive amount of alcohol?New
- Psychosocial interventions (12)
- Alcoholics Anonymous and other 12-step programs for alcohol use disorder
- Alcoholics Anonymous and other 12-step programmes for alcohol dependence
- Brief interventions for heavy alcohol users admitted to general hospital wards
- Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations
- Effectiveness of brief alcohol interventions in primary care populations
- Interventions to build resilience in children of problem drinkers
- Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries
- Motivational interviewing for the prevention of alcohol misuse in young adults
- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy.
- Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy
- What are the effects of combined psychosocial interventions and medications for helping people who consume an excessive amount of alcohol?New
- Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
- Alcohol acute intoxication interventions (0)
- Other (2)
- Preventive interventions (6)
- Cocaine abuse and dependence (8)
- Preventive interventions (0)
- Pharmacological interventions (6)
- Anticonvulsants for cocaine dependence
- Antidepressants for cocaine dependence and problematic cocaine use
- Antipsychotic medications for cocaine dependence
- Disulfiram for the treatment of cocaine dependence
- Dopamine agonists for the treatment of cocaine dependence
- Psychostimulant drugs for cocaine dependence
- Psychosocial interventions (1)
- Cocaine and other psychostimulants acute intoxication interventions (0)
- Other (1)
- Amphetamine and amphetamine type stimulants (ATS) abuse and dependence (3)
- Preventive interventions (0)
- Pharmacological interventions (2)
- Psychosocial interventions (1)
- Amphetamine and ATS acute intoxication interventions (0)
- Other (0)
- Hallucinogens abuse and dependence (0)
- Preventive interventions (0)
- Pharmacological interventions (0)
- Psychosocial interventions (0)
- Other (0)
- Cannabis abuse and dependence (4)
- Preventive interventions (0)
- Pharmacological interventions (2)
- Psychosocial interventions (2)
- Other (0)
- Inhalants (1)
- Preventive interventions (0)
- Pharmacological interventions (1)
- Psychosocial interventions (0)
- Other (0)
- Iatrogenic use of prescribed drugs (0)
- Preventive interventions (0)
- Pharmacological interventions (0)
- Psychosocial interventions (0)
- Other (0)
- Polydrug (16)
- Preventive interventions (4)
- Media campaigns for the prevention of illicit drug use in young people
- Individual-, family-, and school-level interventions for preventing multiple risk behaviours relating to alcohol, tobacco and drug use in individuals aged 8 to 25 years
- Interventions for prevention of drug use by young people delivered in non-school settings
- Universal school-based prevention for illicit drug use
- Pharmacological interventions (0)
- Psychosocial interventions (8)
- Brief school-based interventions and behavioural outcomes for substance-using adolescents
- Psychological interventions for co-occurring depression and substance use disorders
- Effectiveness of psychosocial interventions for reducing parental substance misuse
- Motivational interviewing for substance use reduction
- Mentoring adolescents to prevent drug and alcohol use
- Mindfulness-based interventions for substance use disorders
- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions
- Therapeutic communities for substance related disorder
- Pharmacological and/or psychosocial interventions (3)
- Other (1)
- Preventive interventions (4)
- Otherdrug (3)
- Preventive interventions (0)
- Pharmacological interventions (2)
- Psychosocial interventions (1)
- Diagnostic test (1)